Retatrutide is a new medication in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By stimulating these receptors, Retatrutide controls cravings, {promotesenergy expenditure, and ultimately results in significant reduction in body mass. Whil… Read More